2011-08-18 05:00:40 - Recently published research from Global Markets Direct, "Arthritis - Pipeline Review, Q3 2011", is now available at Fast Market Research

Arthritis - Pipeline Review, Q3 2011

Summary

Global Markets Direct's, 'Arthritis - Pipeline Review, Q3 2011', provides an overview of the Arthritis therapeutic pipeline. This report provides information on the therapeutic development for Arthritis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Arthritis. 'Arthritis - Pipeline Review, Q3 2011' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the

indicated disease.


Full Report Details at
- www.fastmr.com/prod/215166_arthritis_pipeline_review_q3_2011.asp ..


Scope

* A snapshot of the global therapeutic scenario for Arthritis.

A review of the Arthritis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

Coverage of products based on various stages of development ranging from discovery till registration stages.

A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

Coverage of the Arthritis pipeline on the basis of therapeutic class, route of administration and molecule type.

Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.

Key discontinued pipeline projects.

Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Arthritis.

Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.

Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.

Devise corrective measures for pipeline projects by understanding Arthritis pipeline depth and focus of Arthritis therapeutics.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.


Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Arthritis Overview
Therapeutics Development
An Overview of Pipeline Products for Arthritis
Arthritis Therapeutics under Development by Companies
Arthritis Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Arthritis Therapeutics - Products under Development by Companies
Arthritis Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Arthritis Therapeutics Development
Johnson & Johnson
Seikagaku Corporation
Targeted Genetics Corporation
Cytokine PharmaSciences, Inc.
Novartis AG
Daewoong Pharmaceutical Co., Ltd.
Pfizer Inc.
Zydus Cadila Healthcare Limited
Bone Medical Limited
AnaMar Medical AB
CREABILIS Therapeutics S.r.l.
PLx Pharma Inc.
TissueGene, Inc.
Endocyte, Inc.
NasVax Ltd.
Zeltia, S.A.
Kemin Industries, Inc.
Cellceutix Pharmaceuticals, Inc.
Arthritis - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
CP-690,550 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ACZ885 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
DWJ502 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Stelara - Drug Profile
Product Description
Mechanism of Action
R&D Progress
tgAAC94 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
TissueGene-C - Drug Profile
Product Description
Mechanism of Action
R&D Progress
KM 278 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ZYD1 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MX-4042 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Piroxicam - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Meloxicam - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PL 5100 Diclofenac - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PL 3100 Naproxen - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PL 3100 Naproxen - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PL 1100 Ibuprofen - Drug Profile
Product Description
Mechanism of Action
R&D Progress
KPE06001 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
EC0746 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Orfadin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CT340 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Drug For Arthritis - Drug Profile
Product Description
Mechanism of Action
R&D Progress

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=215166&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.